When Is DMEK Needed for Fuchs’ Dystrophy?

Your Fuchs’ dystrophy does not automatically mean you need a corneal transplant. If your symptoms are mild, your ophthalmologist may simply monitor your eyes and recommend non-surgical treatment.

DMEK may be considered for you when Fuchs’ dystrophy causes visually significant corneal swelling or vision problems and your ophthalmologist believes surgery is appropriate. It replaces the unhealthy inner layer of your cornea rather than your entire cornea, helping restore clearer vision.

What Is Fuchs’ Endothelial Corneal Dystrophy?

Fuchs’ endothelial corneal dystrophy affects the cells at the back of your cornea that help remove excess fluid. As these cells become less effective, fluid can build up and cause corneal swelling.

Your vision may then become blurred, hazy or more affected by glare. Fuchs’ dystrophy usually affects both eyes, although one eye may be more affected than the other.

What Does Fuchs’ Dystrophy Do to Your Vision?

Your Fuchs’ dystrophy may cause no noticeable vision changes at first, although your ophthalmologist may spot corneal changes during an eye examination. As your endothelial cells become less effective, you may develop blurred or fluctuating vision.

Your vision can be worse when you wake up and improve during the day as some corneal fluid clears. As Fuchs’ dystrophy progresses, your blur and glare may become more persistent.

Does Everyone With Fuchs’ Dystrophy Need DMEK?

Your Fuchs’ dystrophy does not automatically mean you need DMEK. If your vision remains good and your symptoms are mild, your ophthalmologist may simply monitor your eyes or recommend non-surgical treatment.

DMEK may be considered for you when corneal swelling causes significant visual problems that affect your daily life and your ophthalmologist believes surgery is appropriate. Your specialist will base this decision on how much your condition is affecting you.

What Is DMEK?

DMEK (Descemet membrane endothelial keratoplasty) replaces the damaged inner layer of your cornea with healthy donor tissue. Most of your own cornea remains in place, unlike a full-thickness corneal transplant.

Your new endothelial cells can take over the job of removing excess fluid from your cornea. This can reduce swelling and help improve your corneal clarity and vision.

When Is DMEK Usually Considered?

DMEK may be considered for you when Fuchs’ dystrophy causes persistent corneal swelling, blurred vision or significant discomfort. You may find reading, driving or other everyday activities becoming more difficult.

DMEK may be considered when Fuchs’ dystrophy is causing visually significant corneal changes or symptoms and your ophthalmologist believes surgery is appropriate. The timing depends on your vision, corneal condition, symptoms and overall eye health rather than on one measurement alone.

Treatment Options for Fuchs’ Dystrophy

Treatment approach	When it may be considered	What it involves
Monitoring	Mild or stable Fuchs’ dystrophy with little or no effect on vision	Regular eye examinations to monitor corneal health and vision.
Non-surgical treatment	Mild symptoms caused by corneal swelling	Treatments such as sodium chloride eye drops or ointment may help reduce corneal swelling and symptoms.
DMEK	Significant corneal swelling and visual problems affecting daily life	Replaces the damaged endothelial layer with a very thin donor graft.
DSAEK	Selected patients where endothelial keratoplasty is needed but DMEK may not be suitable	Replaces the damaged endothelial layer with a thicker donor tissue graft containing additional corneal tissue.
Descemet stripping only (DSO)	Selected cases with suitable remaining endothelial cells	Removes diseased central Descemet membrane without inserting donor tissue. Its role is still evolving, and standard indications have not yet been established.
Full-thickness corneal transplant	Significant corneal scarring or damage involving deeper corneal layers	Replaces the full thickness of the cornea rather than only the endothelial layer.

Is There a Specific Endothelial Cell Count That Means You Need DMEK?

Your endothelial cell count is useful, but there is no single number that automatically means you need DMEK. Your ophthalmologist will also consider your corneal thickness, swelling, vision and symptoms.

Your specialist will look at how well your cornea is functioning overall and how much Fuchs’ dystrophy is affecting your daily life. This helps determine whether DMEK is appropriate for you.

Evidence Note

Research into when to perform endothelial keratoplasty for Fuchs’ dystrophy shows that there is no single measurement that can determine the right time for surgery for every patient. Recent reviews describe surgical decisions as being based on several factors, including visual acuity, corneal thickness, corneal imaging and the extent to which the disease is affecting vision.

This means your endothelial cell count is only one part of the assessment. Your ophthalmologist will consider the overall condition of your cornea and how much your symptoms are affecting your daily life before recommending DMEK.

What Symptoms Suggest That Fuchs’ Dystrophy Is Getting Worse?

Your Fuchs’ dystrophy may be progressing if your morning blur becomes more persistent, your vision stays hazy or glare and halos become more noticeable. You may also find that your glasses no longer improve your vision as much.

Your worsening corneal swelling can sometimes cause discomfort or pain. If you notice changes in your vision or increasing symptoms, your ophthalmologist should reassess your eyes.

What Happens During a DMEK Procedure?

During DMEK surgery, your surgeon removes the damaged endothelial layer and places a very thin donor graft containing healthy cells onto the back of your cornea. An air or gas bubble helps hold the graft in position while it attaches.

Your surgeon will explain the anaesthetic and aftercare needed for you. You may also need to keep your head in a particular position after surgery to help the graft settle correctly.

Why Is DMEK Different From a Full Corneal Transplant?

DMEK replaces only the damaged inner endothelial layer and Descemet’s membrane, while most of your own cornea remains in place.

Your recovery and visual results can therefore differ from those of a full corneal transplant. However, your suitability for DMEK depends on which parts of your cornea are affected.

How Is Your Suitability for DMEK Assessed?

Your ophthalmologist will check whether your vision problems are mainly caused by Fuchs’ dystrophy and corneal swelling. Your cornea and the rest of your eye will also be examined for conditions that could affect your results.

Your surgeon will also consider your previous eye surgery and whether you can follow the required aftercare, including positioning after your operation. These factors help determine whether DMEK is suitable for you.

UK Guidance Note

In UK clinical practice, treatment for Fuchs’ dystrophy depends on your symptoms, vision and the severity of the disease. Mild disease may be monitored, while treatment may be considered when corneal swelling begins to affect your vision or daily activities.

DMEK is one type of endothelial keratoplasty that replaces the unhealthy inner layer of your cornea. Your ophthalmologist will assess whether DMEK or another treatment is appropriate by considering your corneal condition, vision, symptoms and overall eye health.

Can Cataract Surgery and DMEK Be Done Together?

Your cataract surgery and DMEK can sometimes be performed together when both your cataract and Fuchs’ dystrophy are significantly affecting your vision. Your surgeon may also recommend treating the two conditions separately, depending on your corneal health.

Your treatment plan will be based on your lens, cornea and overall visual needs. Your surgeon can explain which approach is most suitable for you.

Research Insight

Research comparing DMEK with DSAEK has generally found better visual outcomes and a lower risk of graft rejection with DMEK, although graft detachment requiring additional air or gas treatment can occur more often. These differences do not mean that DMEK is suitable for every eye, because the condition of your cornea and the complexity of surgery also influence the choice.

Research comparing combined cataract surgery with DMEK and staged procedures has not established one approach as universally better. Studies have limitations, and your surgeon may recommend combined or separate procedures depending on the severity of your cataract, the condition of your cornea and your individual visual needs.

Are There Alternatives to DMEK for Fuchs’ Dystrophy?

DMEK is not the only treatment option for advanced Fuchs’ dystrophy. Depending on your corneal condition, your surgeon may consider other procedures based on the extent of endothelial damage.

• DSAEK: This procedure replaces the damaged endothelial layer with donor tissue and may be suitable in some cases.
• Descemet stripping only: In selected patients with milder disease, removing the damaged Descemet membrane may allow healthy endothelial cells to recover the cornea.
• Corneal scarring matters: Significant scarring or other corneal damage may affect whether these alternatives are appropriate.
• Your individual assessment is important: Your ophthalmologist will examine your cornea and consider your vision, disease severity and overall eye health.

The most suitable procedure depends on the condition of your cornea and the extent of Fuchs’ dystrophy. Your ophthalmologist can explain which treatment options are appropriate for your individual needs.

What Can You Expect Immediately After DMEK?

Your vision will usually be blurred immediately after DMEK because the air or gas bubble supports your donor graft. You may also notice redness, watering, mild discomfort or light sensitivity.

Your surgeon will prescribe eye drops, which may include steroid drops to help protect the graft from rejection, and arrange follow-up appointments to monitor your recovery. You should use your drops exactly as prescribed and should not stop steroid treatment unless your corneal team advises you to do so. You should also avoid rubbing or pressing on your eye while the graft is settling.

Why Do You Need to Lie Flat After DMEK?

Your donor graft needs to stay against the back of your cornea while it attaches. Lying flat on your back helps the air or gas bubble press gently against the graft and keep it in position.

Your surgeon will tell you how long you need to posture because your instructions may vary from someone else’s. Following your own positioning plan carefully can help support your graft as it heals.

Clinical Tip

After DMEK, your surgeon will give you specific instructions about lying flat and positioning your head so that the air or gas bubble can support the donor graft while it attaches. Follow the positioning schedule given to you rather than relying on general advice from other patients.

If you are unsure about how long you should posture, how you should sleep or whether you can change position, contact your surgical team for advice. Your instructions may vary depending on how your graft is positioned and how your eye is recovering.

How Long Does Vision Take to Improve After DMEK?

Your vision can improve relatively quickly after DMEK, but it will not usually be clear immediately. Your early blur can be caused by the air or gas bubble and the time your new endothelial cells need to restore your cornea’s fluid balance.

Your recovery depends on how swollen your cornea was before surgery and whether you have other eye conditions. Your vision may continue improving over several weeks or months as your cornea becomes clearer.

What Are the Main Risks of DMEK?

DMEK carries some risks, including graft detachment, which may mean your surgeon needs to reposition the graft with additional air or gas. Graft rejection, graft failure, infection and changes in eye pressure can also occur.

Your individual risks depend on your eye health and previous surgery. Your surgeon will discuss these risks with you and explain what they mean for your particular eyes.

What Are the Signs of Graft Rejection?

Graft rejection is uncommon after DMEK, but you should know the warning signs. You may notice worsening blurred vision, increasing redness, discomfort or greater sensitivity to light.

These symptoms can have other causes, so you should not diagnose rejection yourself. If you have had a corneal transplant and notice new or worsening symptoms, contact your eye specialist promptly and continue using your prescribed drops as directed.

Myth vs Fact

Myth	Fact
Everyone with Fuchs’ dystrophy eventually needs DMEK.	Not everyone needs surgery. Mild or stable disease may only require monitoring or non-surgical treatment.
A low endothelial cell count automatically means you need DMEK.	There is no single cell-count threshold that determines surgery for everyone. Your symptoms, vision, corneal swelling and other findings are also important.
DMEK replaces the whole cornea.	DMEK replaces the damaged inner endothelial layer and Descemet’s membrane while most of your own cornea remains in place.
DMEK and DSAEK are exactly the same procedure.	Both replace unhealthy endothelial tissue, but DMEK uses a thinner donor graft while DSAEK uses a thicker graft containing additional corneal tissue.
Your vision will be clear immediately after DMEK.	Vision is usually blurred immediately after surgery and can continue improving as the graft settles and the cornea clears.
If your vision is blurry after DMEK, the operation has failed.	Early blurred vision can be part of normal recovery. Your surgeon will monitor your cornea and graft to assess how you are healing.
You must always have DMEK and cataract surgery separately.	In some patients, cataract surgery and DMEK can be performed together. In others, your surgeon may recommend separate procedures.
DMEK has no significant risks because it is a partial-thickness transplant.	DMEK carries some risks, including graft detachment, which may mean your surgeon needs to reposition the graft with additional air or gas. Graft rejection, graft failure, infection and changes in eye pressure can also occur.
Graft rejection cannot be treated.	Rejection can sometimes be treated successfully when recognised promptly, so new or worsening symptoms should be assessed quickly.
Fuchs’ dystrophy comes back in the transplanted donor tissue.	Fuchs’ dystrophy primarily affects your own endothelial cells, and DMEK replaces the damaged tissue with donor endothelial cells. However, graft complications or failure can still occur after surgery.
Descemet stripping only is a standard replacement for DMEK.	DSO may be suitable for selected patients, but it is not yet routine treatment in many settings.

Key Takeaways

• Fuchs’ dystrophy does not automatically mean that you need DMEK.
• Mild disease may be monitored or managed with non-surgical treatment.
• DMEK is usually considered when corneal swelling and vision problems are significantly affecting your daily life.
• There is no single endothelial cell count that determines when you need DMEK.
• Your ophthalmologist will consider your vision, symptoms, corneal swelling, imaging and overall eye health.
• DMEK replaces the unhealthy inner endothelial layer rather than the whole cornea.
• DSAEK may be an alternative in selected patients.
• DMEK and cataract surgery can sometimes be performed together, while other patients may need staged treatment.
• Vision is usually blurred immediately after DMEK and may continue improving over weeks or months.
• Following your surgeon’s positioning and eye-drop instructions is an important part of recovery.
• Graft detachment, rejection, graft failure, infection and changes in eye pressure are possible complications.
• New or worsening pain, redness, light sensitivity or blurred vision after surgery should be assessed promptly.

Frequently Asked Questions

1. What is DMEK for Fuchs’ dystrophy?
   DMEK (Descemet membrane endothelial keratoplasty) is a corneal transplant procedure that replaces the damaged inner endothelial layer of your cornea with healthy donor tissue. Most of your own cornea remains in place.
2. Does everyone with Fuchs’ dystrophy need DMEK?
   No. Your Fuchs’ dystrophy does not automatically mean you need surgery. If your symptoms are mild and your vision remains good, your ophthalmologist may recommend monitoring or non-surgical treatment.
3. When is DMEK usually considered?
   DMEK may be considered for you when persistent corneal swelling is significantly affecting your vision or daily activities and your ophthalmologist believes surgery is appropriate. Your ophthalmologist will consider your symptoms, corneal clarity and overall eye health.
4. Is there a specific endothelial cell count that means you need DMEK?
   No. There is no single endothelial cell count that automatically means you need DMEK. Your specialist will also consider your corneal thickness, swelling, vision and symptoms.
5. How is your suitability for DMEK assessed?
   Your ophthalmologist will assess whether your vision problems are mainly related to Fuchs’ dystrophy and corneal swelling. They will also consider your overall eye health, previous eye surgery and whether you can follow the required aftercare.
6. Can you have cataract surgery and DMEK at the same time?
   Yes. Your surgeon may sometimes perform cataract surgery and DMEK together when both conditions are significantly affecting your vision. In other cases, the procedures may be planned separately depending on your corneal health and visual needs.
7. What happens during DMEK surgery?
   Your surgeon removes the damaged endothelial layer and places a very thin donor graft containing healthy cells onto the back of your cornea. An air or gas bubble helps hold the graft in position while it attaches.
8. How long does vision take to improve after DMEK?
   Your vision is usually blurred immediately after surgery and may gradually improve as the donor cells restore your cornea’s fluid balance. Vision can continue improving over several weeks or months depending on your eye health and recovery.
9. Why do you need to lie flat after DMEK?
   Lying flat helps the air or gas bubble press against the donor graft and keep it in position while it attaches to your cornea. Your surgeon will give you specific positioning instructions based on your operation.
10. What are the main risks of DMEK?
    DMEK can involve risks such as graft detachment, which may require additional treatment, as well as graft rejection, graft failure, infection and changes in eye pressure. Your surgeon will discuss your individual risks and aftercare with you.

Final Thoughts: DMEK for Fuchs’ Dystrophy

DMEK may be considered when Fuchs’ dystrophy causes significant corneal swelling and vision problems and your ophthalmologist believes surgery is appropriate. Your symptoms, corneal health, vision and overall eye condition will all be considered when your ophthalmologist assesses whether DMEK is suitable for you.

If you’re considering cataract surgery in London and want to understand how your cataracts and Fuchs’ dystrophy may affect your treatment options, you can get in touch with the Eye Clinic London team to arrange a consultation.

References:

1. Tourabaly, M., Knoeri, J., Georgeon, C. and Borderie, V. (2025) ‘Review of the literature: Surgery indications for Fuchs’ endothelial corneal dystrophy’, Journal of Clinical Medicine, 14(7), 2365. Available at: https://www.mdpi.com/2077-0383/14/7/2365
2. Altamirano, F., Ortiz-Morales, G., O’Connor-Cordova, M.A., Sancén-Herrera, J.P., Zavala, J. and Valdez-Garcia, J.E. (2024) ‘Fuchs endothelial corneal dystrophy: an updated review’, International Ophthalmology, 44(1), 61. Available at: https://pubmed.ncbi.nlm.nih.gov/38345780/
3. Esteves Marques, R., Silva Guerra, P., Cordeiro Sousa, D., Gonçalves, A.I., Quintas, A.M. and Rodrigues, W. (2019) ‘DMEK versus DSAEK for Fuchs’ endothelial dystrophy: a meta-analysis’, European Journal of Ophthalmology, 29(1), pp. 15–22. Available at: https://pubmed.ncbi.nlm.nih.gov/29661044/
4. Blitzer, A.L. and Colby, K.A. (2020) ‘Update on the surgical management of Fuchs endothelial corneal dystrophy’, Ophthalmology and Therapy, 9(4), pp. 757–765. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC7708572/
5. Ali, M., Cho, K. and Srikumaran, D. (2023) ‘Fuchs Dystrophy and Cataract: Diagnosis, Evaluation and Treatment’, Ophthalmology and Therapy, 12(2), pp. 691–704. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC10011243/